VanNess & VanNess, P.A.

FDA Approves New Treatment for Lung Cancer/Mesothelioma Patients

The United States Food and Drug Administration (FDA) recently approved Opdivo, an advanced lung cancer drug. Opdivo is the first immuno-oncology drug therapy for patients with lung cancer. Mesothelioma and lung cancer are caused by exposure and inhalation of dangerous asbestos fibers. Patients usually receive chemotherapy as their first choice of treatment to treat this difficult disease. However, Mesothelioma often reoccurs as it is considered chemo resistant, making the disease difficult to treat. Opdivo now offers patients a different treatment modality after chemotherapy. Dr. Suresh Ramalingam, M.D. Professor, Chief of Thoracic Oncology and Director of Medical Oncology, Winship Cancer Institute of Emory University, stated "This milestone brings to fruition the long held hope that immune-oncology medicines can be significantly effective in this difficult to treat population."

This newly approved FDA drug may improve survival for Mesothelioma and lung cancer patients. If you have been diagnosed with Mesothelioma or lung cancer and are searching for alternative treatments after chemotherapy, ask your doctor about Opdivo. This new drug provides patients, exposed to dangerous asbestos fibers, a new treatment modality for extending survival rates and quality time with their families.

No Comments

Leave a comment
Comment Information
Email Us For A Response

Discuss Your Case With An Experienced Attorney

Bold labels are required.

Contact Information

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.


Privacy Policy

Office Location

1205 N. Meeting Tree Blvd.
Crystal River, FL 34429

Toll Free: 866-697-6221
Phone: 352-436-4333
Crystal River Law Office Map

250 International Parkway
Suite 340
Lake Mary, Florida 32746

Toll Free: 866-697-6221
Phone: 352-436-4333
Map & Directions

Office Location